A Randomized Placebo-Controlled Study of Vernakalant (Oral) for the Prevention of Atrial Fibrillation Recurrence Post-Cardioversion

Study Questions:

How effective is vernakalant for preventing recurrent atrial fibrillation (AF) after direct-current cardioversion?